iShares Biotechnology ETF (NASDAQ:IBB) Shares Bought by Summit Financial LLC

Summit Financial LLC increased its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 10.7% during the second quarter, Holdings Channel reports. The firm owned 6,346 shares of the financial services provider’s stock after purchasing an additional 614 shares during the period. Summit Financial LLC’s holdings in iShares Biotechnology ETF were worth $871,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Essex Financial Services Inc. boosted its position in shares of iShares Biotechnology ETF by 16.3% in the 2nd quarter. Essex Financial Services Inc. now owns 8,191 shares of the financial services provider’s stock valued at $1,124,000 after purchasing an additional 1,146 shares during the period. Bray Capital Advisors boosted its holdings in shares of iShares Biotechnology ETF by 1.7% in the second quarter. Bray Capital Advisors now owns 19,169 shares of the financial services provider’s stock worth $2,631,000 after buying an additional 313 shares during the period. Farther Finance Advisors LLC increased its position in shares of iShares Biotechnology ETF by 4.9% in the second quarter. Farther Finance Advisors LLC now owns 3,506 shares of the financial services provider’s stock worth $480,000 after acquiring an additional 163 shares in the last quarter. Graypoint LLC acquired a new stake in shares of iShares Biotechnology ETF during the second quarter valued at approximately $204,000. Finally, Baltimore Washington Financial Advisors Inc. lifted its position in shares of iShares Biotechnology ETF by 3.0% in the 2nd quarter. Baltimore Washington Financial Advisors Inc. now owns 7,411 shares of the financial services provider’s stock valued at $1,017,000 after acquiring an additional 213 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.1 %

NASDAQ IBB opened at $148.17 on Tuesday. The firm’s 50 day moving average price is $143.60 and its two-hundred day moving average price is $137.77. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.17.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.